brief lecture notes for 5th sem MBBS, on portal hypertension and varices. Introduction to portal hypertension and esophageal and gastric varices and management of variceal bleeding.
brief lecture notes for 5th sem MBBS, on portal hypertension and varices. Introduction to portal hypertension and esophageal and gastric varices and management of variceal bleeding.
Cholangiocarcinoma: Pathology, diagnosis and treatment.Marco Castillo
A brief description with many abdominal imaging of the Cholangiocarcinoma.
Includes definition, epidemiology, pathology, classification, clinical presentation, diagnosis, staging and treatment.
A brief description on Cholangiocarcinoma, its classification and management. Contains management of Intrahepatic cholangiocarcinoma, Perihilar cholangiocarcinoma, Distal cholangiocarcinoma.
Cholangiocarcinomas (bile duct cancers) arise from the epithelial cells of the intrahepatic and extrahepatic bile ducts.
Please do not edit or rename.
Note it is only for academic purposes.
Cholangiocarcinoma: Pathology, diagnosis and treatment.Marco Castillo
A brief description with many abdominal imaging of the Cholangiocarcinoma.
Includes definition, epidemiology, pathology, classification, clinical presentation, diagnosis, staging and treatment.
A brief description on Cholangiocarcinoma, its classification and management. Contains management of Intrahepatic cholangiocarcinoma, Perihilar cholangiocarcinoma, Distal cholangiocarcinoma.
Cholangiocarcinomas (bile duct cancers) arise from the epithelial cells of the intrahepatic and extrahepatic bile ducts.
Please do not edit or rename.
Note it is only for academic purposes.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
1. Vascular Disorders of the Liver
By
Ahmed Abudeif Abdelaal
Assistant Lecturer of Tropical Medicine & Gastroenterology
Sohag Faculty of Medicine
December, 2017
2. Introduction
- All liver disorders related to a primary injury to hepatic
vessels qualify as rare diseases, affecting less than 5/10000
patients.
- Their recognition requires a high degree of suspicion, as
well as awareness and expertise in the interpretation of
vascular imaging and liver histopathology.
3. Introduction
- Many patients with primarily vascular disorders of the liver
will be misdiagnosed as having common liver diseases,
particularly cirrhosis.
4. Classification of vascular disorders of the liver
A) Disorders of the hepatic arteries:
1. Hepatic artery occlusion.
2. Hepatic artery aneurysm.
3. Arterioportal and arteriovenous fistulae.
B) Disorders of the hepatic veins and IVC:
• Budd-Chiari syndrome (BCS).
5. Classification of vascular disorders of the liver
C) Disorders of extrahepatic portal vein:
1. Portal vein thrombosis (PVT).
2. Congenital portohepatic shunts.
3. Portal vein aneurysm.
D) Disorders of intrahepatic portal venous system:
1. Obliterative portal venopathy.
2. Portohepatic fistulae.
6. Classification of vascular disorders of the liver
E) Disorders of sinusoids:
1. Sinusoidal obstruction syndrome (SOS).
2. Sinusoidal dilatation and peliosis hepatis.
3. Sinusoidal fibrosis.
7. Disorders of the hepatic arteries
A) Hepatic artery occlusion:
- Very rare condition.
Causes:
1) Polyarteritis nodose (PAN).
2) Giant cell arteritis.
3) Embolism as in infective endocarditis.
4) Tied during surgery e.g. cholecystectomy.
5) Trauma as in laparoscopic cholecystectomy.
8. Disorders of the hepatic arteries
A) Hepatic artery occlusion:
Clinical picture: until now the condition is highly fatal.
- Features of the cause.
- Sudden pain in the right upper abdomen, followed by
collapse and hypotension.
- RUQ tenderness.
- The condition progresses to liver cell failure.
9. Disorders of the hepatic arteries
A) Hepatic artery occlusion:
Diagnosis:
1) Hepatic angiography: the obstruction will be shown.
2) Scanning: show infarcts and maybe the occluded vessels.
Treatment:
Treatment of the cause, and LCF if present.
10. Hepatic angiogram showing
occluded hepatic artery
CT abdomen show abscess formation
secondary to liver infarction after
hepatic artery thrombosis
11. Hepatic artery thrombosis, results in
hilar infarction involves the major bile
ducts, and extends into the corpus of the
liver.
12. Disorders of the hepatic arteries
B) Hepatic artery aneurysm:
- Rare, but make up to 1/5 of all visceral aneurysms.
Causes:
1) Congenital.
2) Blunt or penetrating trauma (including liver biopsy).
3) PAN.
4) Infective endocarditis.
5) Atherosclerosis.
13. Disorders of the hepatic arteries
B) Hepatic artery aneurysm:
Clinical picture:
- Abdominal pain is frequent.
- The classical triad of jaundice, abdominal pain, haemobilia is
present in only 1/3 of the cases.
- The majority of patients present for the first time with
rupture resulting in haemoperitoneum, haemobilia or
haematemesis.
14. Disorders of the hepatic arteries
B) Hepatic artery aneurysm:
Diagnosis:
- The diagnosis is suggested by sonography and confirmed
by hepatic arteriography and a CT scan after enhancement.
Treatment:
- Angiographic embolization or surgical ligation.
17. Disorders of the hepatic arteries
C) Arterioportal and arteriovenous fistulae:
Causes:
1) Blunt or penetrating trauma (including liver biopsy).
2) Neoplasm usually HCC.
3) Rupture of hepatic artery aneurysm.
4) Part of hereditary haemorrhagic telangiectasia.
18. Disorders of the hepatic arteries
C) Arterioportal and arteriovenous fistulae:
Clinical picture:
- Arterioportal shunts may present with portal hypertension,
heart failure, while arteriovenous shunts may present with
heart failure.
- Large shunts cause a bruit in the RUQ.
19. Disorders of the hepatic arteries
C) Arterioportal and arteriovenous fistulae:
Diagnosis:
- Confirmed by hepatic angiography.
Treatment:
- Embolization with particles and/or placement of occluding
devices.
20. Arterial Phase Coronal CT shows a
fistula between the right hepatic artery
and right portal vein with resulting
severe dilatation of the main portal
vein. Yellow Arrow: Right Hepatic
Artery. Blue Arrow: Right Portal Vein
21. Disorders of the hepatic veins and IVC
- Obstruction of the hepatic veins and terminal IVC
corresponds to Budd-Chiari syndrome (BCS).
Budd-Chiari syndrome:
Definition:
- obstruction of hepatic venous outflow that can be located
from the small hepatic venules up to the entrance of the IVC
into the right atrium.
22. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Definition:
- Hepatic outflow obstruction related to cardiac disease,
pericardial disease or sinusoidal obstruction syndrome
(SOS) are excluded from this definition.
23. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Classification:
- BCS can be classified into:
A) Primary: caused by thrombosis in the absence of
compression by space occupying lesions, or invasion by
malignancy or parasites.
B) Secondary: otherwise.
25. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Clinical picture:
- Ranges from asymptomatic to fulminant LCF.
- Acute form: picture of acute LCF.
- Chronic form: the patient may present with triad of
abdominal pain, hepatomegaly, ascites. Negative
hepatojugular reflux. Finally LCF and portal hypertension
occurs.
26. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Clinical picture:
- Asymptomatic BCS: account for up to 15% of cases. The
condition is diagnosed accidentally, either by imaging or by
the investigation of abnormal liver function tests.
27. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Diagnosis:
- Early diagnosis depends on doppler US and contrast
enhanced MRI, where abnormalities in the direction of flow
in the hepatic vein and IVC, is revealed.
- CT and/or angiography can be used.
28. Hepatic venogram in a patient with
BCS. Note the lace-like spider-web
pattern.
MRI in a patient with the BCS showing a liver
(L) which is dyshomogeneous, the aorta (A)
and the inferior vena cava (V). The side-to-
side narrowing of the inferior vena cava
(arrows) is due to the enlarged caudate lobe.
30. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Treatment:
- Early treatment of the underlying cause.
- Long term anticoagulation is given to all patients.
- Angioplasty/stenting should be considered in patients with
short segment hepatic vein stenosis, IVC stenosis or to
dilate webs.
31. Disorders of the hepatic veins and IVC
Budd-Chiari syndrome:
Treatment:
- TIPS, should be considered if anticoagulation and/or
angioplasty/stenting failed.
- Surgical portosystemic shunts are indicated only if TIPS is
not available or cannot be fashioned.
- Liver transplantation is indicated when TIPS/surgical
shunting have failed.
32. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
- This is the most common of the vascular disorders of the
liver.
- Portal vein thrombosis (PVT) may be:
1. Acute.
2. Chronic.
33. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
- Acute PVT is defined as a recent formation of a thrombus
within the portal vein and/or right or left branches.
- The thrombus may extend into the mesenteric or splenic
veins; occlusion may be complete or partial.
34. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
- Following acute thrombosis, in the absence of
recanalization, the portal venous lumen obliterates and
portoportal collaterals develop. This process is called
cavernomatous transformation, the result of which is the
portal cavernoma. Chronic PVT has been used to
designate the latter condition.
35. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Causes:
- May be due to local factors (e.g. infiltration by tumour or
trauma) and/or underlying prothrombotic conditions.
Clinical picture:
- Features of the underlying cause.
36. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Clinical picture:
- Acute PVT:
Acute abdominal pain in 90% of cases.
SIRS is present in 85% of patients even in absence of an
inflammatory focus.
Prolonged total obstruction leads to intestinal perforation,
peritonitis, shock and death.
37. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Clinical picture:
- Chronic PVT:
There is manifestations of portal hypertension with bleeding varices
is the most common presentation.
Portal cholangiopathy, a condition characterized by compression
and deformation of intra- and extrahepatic bile ducts by the
collateral veins constituting the cavernoma.
38. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Diagnosis:
1. Abdominal US, CT and MRI can show thrombus.
2. Doppler US show flow in collaterals with no PV signal.
3. EUS can detect small non-occluding thrombi.
4. Angiography.
42. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Treatment:
- Treatment of underlying cause.
- Treatment of acute PVT:
Anticoagulants should be given to all patients.
Continue on long term anticoagulation in patients with permanent
thrombotic risk factors.
43. Disorders of extrahepatic portal vein
A) Portal vein thrombosis:
Treatment:
- Treatment of chronic PVT:
Screening for varices with treatment of active haemorrhage.
Long term anticoagulation in patients without cirrhosis and with a
permanent thrombotic risk factors.
In children consider portosystemic shunting.
44. Disorders of extrahepatic portal vein
B) Congenital portohepatic shunts:
- They represent persistence of the omphalomesenteric
venous system.
- These shunts divert portal blood away from the liver.
- Clinically there is portosystemic encephalopathy.
- They are diagnosed by ultrasound, CT, MRI and colour
Doppler imaging and confirmed by angiography.
45. Disorders of extrahepatic portal vein
C) Portal vein aneurysm:
- This abnormality is mostly encountered in patients with
portal hypertension and therefore represents a secondary
alteration.
47. Disorders of intrahepatic portal venous system
A) Obliterative portal venopathy:
- Obliteration of small portal veins is usually associated with
portal fibrosis, nodular regenerative changes, and sinusoidal
dilatation or fibrosis.
Causes:
Schistosomiasis.
Chronic exposure to chemicals (arsenic, copper, vinyl chloride,
thorium dioxide).
49. Disorders of intrahepatic portal venous system
A) Obliterative portal venopathy:
Clinical picture:
- Manifestations of the underlying cause.
- Manifestations of portal hypertension.
Treatment:
- Treatment of the cause.
- Treatment of portal hypertension, bleeding varices.
50. Disorders of intrahepatic portal venous system
B) Portohepatic fistulae:
- This rare entity is almost exclusively encountered in patients
with hereditary hemorrhagic telangiectasia.
51. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
- Also known as hepatic veno-occlusive disease (VOD).
- SOS is related to toxic injury to sinusoidal endothelium.
- It is almost exclusively encountered in:
After exposure to certain plants containing pyrrolizidine
alkaloids (chronic form). The alkaloids are ingested in the
form of herbal teas, hence the term Jamaican bush tea
disease. or
52. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
After BMT or haematopoietic stem cell transplantation due
to exposure to high dose cytoreductive therapy, with or
without hepatic irradiation. SOS also associated with several
chemotherapeutic agents used in treatment of solid cancer,
or immunosuppressors used after organ transplantation
(acute form).
54. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
Clinical picture:
A) SOS following BMT has been defined as the occurrence of
two or more of the following characteristics appearing within
20 days after transplantation (Seattle criteria):
Painful hepatomegaly.
55. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
Clinical picture:
Sudden weight gain of more than 2% of baseline body weight.
Total serum bilirubin level greater than 2.0 mg/dL.
B) Chronic form of SOS have features similar to those of
hepatic vein occlusion and include tender hepatomegaly,
abdominal pain, ascites, and fatigue.
56. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
Diagnosis:
- Mainly clinical.
- Transjugular liver biopsy may be helpful.
Treatment:
- Largely supportive with therapy of fluid retention, sepsis,
and organ failure.
57. Disorders of Sinusoids
A) Sinusoidal obstruction syndrome:
Treatment:
- Defibrotide, may be of benefit in prophylaxis or treating
severe SOS, with complete remission in 30-60%.
- TIPS, portosystemic shunting and liver transplantation have
been used in individual cases.
58.
59. Disorders of Sinusoids
B) Sinusoidal dilatation and peliosis hepatis:
- These are rare vascular conditions characterized by a
proliferation of the sinusoidal hepatic capillaries that results
in cystic blood-filled cavities distributed randomly
throughout the liver.
60. Disorders of Sinusoids
B) Sinusoidal dilatation and peliosis hepatis:
- Peliosis is characterized by destruction of the sinusoidal
wall, while in pure sinusoidal dilatation the endothelium
appears to be preserved.
Causes:
63. Disorders of Sinusoids
B) Sinusoidal dilatation and peliosis hepatis:
Clinical picture:
- The condition usually asymptomatic, but when severe, it
manifest as jaundice, hepatomegaly, LCF,
haemoperitoneum.
Diagnosis of peliosis hepatis:
- Diagnosis can established by CT, or MRI.
64. Disorders of Sinusoids
B) Sinusoidal dilatation and peliosis hepatis:
Treatment:
- Treatment of the underlying cause.
- Rarely partial resection of the liver or transplantation may
be required.
67. Disorders of Sinusoids
C) Sinusoidal fibrosis:
- When located in the perivenous area of the lobule, this
lesion is associated frequently with alcoholic or non
alcoholic steatohepatitis, or with longstanding hepatic
venous outflow block or heart failure.
- When randomly distributed, it can accompany obliterative
portal venopathy or sinusoidal dilatation.
68. Disorders of Sinusoids
C) Sinusoidal fibrosis:
- In rare patients, sinusoidal fibrosis is an isolated finding. A
typical cause for isolated sinusoidal fibrosis is chronic
vitamin A supplementation.
Editor's Notes
Depending on speed of occlusion, severity of liver dysfunction, anatomical sites of thrombosis and aetiology.
It may be explained by remaining patency of one large hepatic vein or development of a large venous collateral.
The aim of TIPS is to decompress the liver and reverse portal venous flow, in effect acting as a side-to-side portocaval shunt.
SIRS is defined as 2 or more of the following:
Temperature > 38°C or < 36°C.
Heart rate > 90 beat/min.
Respiratory rate > 20 cycle/min. or PaCO2 < 32 mmHg.
WBC count > 12000 /mm3 or < 4000 /mm3 or > 10% band cells.
Defibrotide: mixture of single-stranded oligonucleotides with multiple antithrombotic, fibrinolytic and angiogenic properties.